Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...
Space Compass and SWISSto12 have executed a procurement contract for the first GEO optical data relay satellite. This agreement represents a milestone toward the realisation of Space Compass’s optical ...
Magnetic rocks with iron oxide concentrations act as natural chroniclers of Earth's past continental movements. Using small ...
(From Left to Right): Julie Pignon, Legal Counsel, SWISSto12; 倉田 るり子 (Ruriko Kurata), Legal Counsel, Space Compass; 小松 大実 (Hiromi Komatsu), Co-CEO, Space Compass; 田中 良太 (Ryota Tanaka), Engineering ...
Investing.com - Stifel reiterated a Buy rating and $12.00 price target on Compass Therapeutics (NASDAQ:CMPX) shares, well above the current stock price of $5.10. The biotech company has delivered a ...
How a firm leads across these four directions—by design or by habit—reveals its true center of gravity far more reliably.
Austin-based fiduciary investment management and technology firm LeafHouse and Global Trust Company (GTC) on April 17 announced a strategic partnership to modernize collective investment trust (CIT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results